NAD+ (buffered)

NAD+ Buffered is a lyophilized nicotinamide adenine dinucleotide formulation prepared with buffering agents to support a more controlled pH during reconstitution and metabolic research applications.

Price range: $40.50 through $72.00

$40.50
1 - 4 vials
$36.45 (10% off)
5 - 9 vials
$32.40 (20% off)
10+ vials
Lot IDPurityNet ContentEndotoxinSterility
NAD050082026199.181%493.76 mg (98.75%)< 0.08 EU/mLPass
NAD100082026199.461%976.43 mg (97.643%)< 0.06 EU/mLPass
Purity
99.181%
Net Content
493.76 mg (98.75%)
Endotoxin
< 0.08 EU/mL
Sterility
Pass
Purity
99.461%
Net Content
976.43 mg (97.643%)
Endotoxin
< 0.06 EU/mL
Sterility
Pass

What is NAD+ Buffered?
NAD+ Buffered is a lyophilized formulation of nicotinamide adenine dinucleotide, an essential coenzyme found in all living cells. NAD+ participates in cellular energy production, redox reactions, mitochondrial metabolism, and enzyme systems involved in DNA repair and cellular signaling.

Why is it Buffered?
Unbuffered NAD+ solutions can be noticeably acidic after reconstitution. The buffered formulation includes pH-modifying excipients intended to create a more controlled solution environment while preserving the biological identity of the NAD+ molecule.

Research Interest
NAD+ is investigated for its central role in cellular metabolism and energy transfer. Research areas include mitochondrial function, oxidative phosphorylation, metabolic regulation, cellular stress responses, DNA repair, and age-associated changes in NAD+ availability.

Mechanisms Under Investigation
NAD+ functions both as an electron-transfer coenzyme and as a substrate for enzymes including sirtuins, poly(ADP-ribose) polymerases (PARPs), and CD38. These pathways connect NAD+ availability with energy metabolism, gene regulation, DNA damage responses, and cellular adaptation to physiological stress.

Current State of Research
NAD+ biology is supported by extensive cellular and preclinical research, while direct administration and NAD+-restoration strategies remain active areas of human investigation. Current studies continue to examine pharmacokinetics, short-term tolerability, metabolic effects, and the differences between direct NAD+ administration and precursor-based approaches.

Batch Details
ID
Content
Received Date
Lot Size
vials
Crimp Color
Cap Color
Testing Lab
Lab ID
Test Date
Peptide Purity
Net Peptide Content
Peptide-to-Excipients Ratio
Endotoxin
Sterility